Company Statistics

Company A the clear choice for 3 today, and tomorrow Innovation Market Quality Company A is committed to empowering you as you strive to continue providing the highest quality diagnostic information for patients. In collaboration with you, our customers, we are working at our industry's forefront to help you improve diagnostic accuracy, lab efficiency, and patient safety. Founded in the spirit of innovation, we continue to focus on addressing unmet medical needs by developing the cutting-edge tools you need. SUCCESS for pathology professionals who wish to elevate the standard of care for cancer patients Innovation leadership Did you know? Company A has won nearly 70% of market share in the US. Company A offers approved assays; Company C offers 2. Company A invests more than twice as Total number of Number of US unique assays patents issued Company A 224 Company A 77 revenues R&D than Company C. Company B 107 Company B 46 Company C 119 Company C 67 Number of cleared Number of new platforms digital algorithms launched since 2008 Company A Company A 4 Company B 0 Company B 0 Company C Company C 1 Partnerships Invested in R&D as a percent of total sales 3 1 partner name o- Company A -o Company B Company C 15% 10% 7% partner name partner name partner name partner name partner name partner name partner name Company A Company B Company C partner name product service product Market 2 leadership Did you know? Leading the industry in innovation, market share, and quality, Company A is the clear choice for professionals who wish to elevate the standard of care for patients. North America North American workflow market share solutions market share Company A Company C Company B 66% 22% Company C Company A Company B Quality leadership Did you know? Company A is growing rapidly-in market share and innovative offerings- with an uncompromising commitment to quality. Number of adverse Number of recalls events reported Company A Company A 0 Company B 0 Company B 9. Company C 71 Company C LO 3.